announced today that the U.S. Food and Medication Administration has issued a Complete Response letter to its New Medication Program for intravenous acetaminophen. In the entire Response letter, the FDA only indicated that deficiencies were observed during the FDA’s service inspection of Cadence’s third party manufacturer, which was finished on February 5, 2010.S. Start of generic AXERT tabletsMylan announces U.S. Release of generic Fusilev for InjectionAlnylam presents positive ongoing stage 2 open-label extension data for Patisiran and RevusiranThe Company’s alternative party manufacturer intends to respond promptly to the observations, and Cadence plans to request a meeting with the FDA to make sure that the deficiencies have already been adequately addressed to meet the requirements for NDA approval.Looking older does not have to be. Patients now have a noninvasive treatment option to reduce the signs of aging and combat wrinkles once and for all – – with no downtime. Gilbert Lee and his group at Changes COSMETIC SURGERY & Spa are actually using Artefill, the initial and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of the mouth area. ‘Dermal fillers continue to grow in popularity among my patients and we find Artefill to be optimal for those who want a long term remedy for wrinkle correction,’ said Dr.